| Peer-Reviewed

Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases

Received: 23 October 2015     Accepted: 3 November 2015     Published: 19 November 2015
Views:       Downloads:
Abstract

Objective: to evaluate the role of US &CT guided percutanous renal biopsy (PRB) in diagnosis and monitoring of renal parenchymal diseases. Patients &Methods: This study included 30 patients who were presented by and/or known cases of renal parenchymal disease referred for US and/or CT guided PRB for etiological & histopathological diagnosis. The histopathological results were correlated with clinical, US & laboratory data for each patient. Results: Out of those 30 patients; 29 patients had adequate PRB (29/30) (96.7%) for histopatholgical diagnosis. Out of those 29 patients; 23 showed increase in renal cortical echogenicity (13 with GI, 8 with GII, &2 with GIII) & 6 cases showed normal echogenicity (G0). The lupus nephritis was the most accounted diagnosis (16/29) (55.2%)(7 with GI, 5 with GII, 4 with G0 cortical echogenicity). The glomerular changes were depicted in 25 cases (13 with GI, 7 with GII, 2 with GIII, 3 with G0), tubular changes in 21 cases (10 with GI, 7 with GII, 2 with GI, 2 with G0), and interstitial changes in 24 cases (12 with GI, 8 with GII, 2 with GIII, 2 with G0). Post biopsy complications (minor) were accounted only in 2 cases (2/30) (6.7%). Conclusions: Ultrasound PRB is the standard method for most non-focal renal biopsies as it has the advantage of real-time needle placement without radiation & fundamental procedure for diagnosis, monitoring &treatment of RPD. US and CT guided PRB is generally considered safe with minimal risk.

Published in International Journal of Medical Imaging (Volume 3, Issue 6)
DOI 10.11648/j.ijmi.20150306.13
Page(s) 114-129
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2015. Published by Science Publishing Group

Keywords

Ultrasound Guided, Renal Biopsy, CT Guided, Renal Parenchymal Disease

References
[1] Stevens PE, O'Donoghue DJ, de LS et al. Chronic kidney disease management in the UnitedKingdom: NEOERICA project results. Kidney Int 2007; 72(1): 92-99.
[2] Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41(1): 1-12.
[3] Barsoum RS. End-stage renal disease in North Africa. Kidney Int Suppl 2003; (83): S111-S114.
[4] Fiorini F, Barozzi L. The role of ultrasonography in the study of medical nephropathy. Journal of Ultrasound 2007; 10(4): 161-167.
[5] Buturovi-ç-Ponikvar J, Visnar-Perovic A. Ultrasonography in chronic renal failure. Eur J Radiol 2003; 46(2): 115-122.
[6] Alebiosu CO, Kadiri S. Percutaneous renal biopsy as an outpatient procedure. J Natl Med Assoc 2004; 96(9): 1215-1218.
[7] Salama AD. Renal biopsy. Medicine 2011; 39(6): 339-342.
[8] Uppot RN, Harisinghani MG, Gervais DA. Imaging-guided percutaneous renal biopsy: rationale and approach. AJR Am J Roentgenol 2010; 194(6): 1443-1449.
[9] Garg AK, Kanitkar M, Venkateshwar V. Clinicopathological spectrum of renal biopsies in children. Medical Journal Armed Forces India 2010; 66(3): 216-219.
[10] Riccabona M, Mache C, Ring E. Renal Parenchymal Disease. In: Fotter R, editor. Pediatric Uroradiology.Berlin, Heidelberg: Springer; 2008. 355-383
[11] Waldo B, Korbet SM, Freimanis MG, Lewis EJ. The value of post-biopsy ultrasound in predicting complications after percutaneous renal biopsy of native kidneys. Nephrology Dialysis Transplantation 2009; 24(8): 2433-2439.
[12] Atwell TD, Smith RL, Hesley GK et al. Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin. AJR Am J Roentgenol 2010; 194(3): 784-789.
[13] Chan KW, Chan TM, Cheng IK. Clinical and pathological characteristics of patients with glomerular diseases at a university teaching hospital: 5-year prospective review. Hong Kong Med J 1999; 5(3): 240-244.
[14] Rahbar M. Kidney biopsy in west of Iran: Complications and histopathological findings. Indian J Nephrol 2009; 19(2): 68-70.
[15] Francis M, Barsoum R. Spectrum of Glomerulonephritis in Egypt. Saudi J Kidney Dis Transpl 2000; 11(3): 421-429.
[16] Al Arrayed A, George SM, Malik AK et al. The spectrum of glomerular diseases in the kingdom of bahrain: An epidemiological study based on renal biopsy interpretation. Transplantation proceedings 2004; 36(6): 1792-1795.
[17] Shawarby M, Al Tamimi D, Al Mueilo S et al. A Clinicopathologic Study of Glomerular Disease: Experience of the King Fahd Hospital of the University, Eastern Province, Saudi Arabia. Hong Kong Journal of Nephrology 2010; 12(1): 20-30.
[18] Ossareh S, Asgari M, Abdi E et al. Renal biopsy findings in Iran: case series report from a referral kidney center. Int Urol Nephrol 2010; 42(4): 1031-1040.
[19] Tang S, Li JH, Lui SL, Chan TM, Cheng IK, Lai KN. Free-hand, ultrasound-guided percutaneous renal biopsy: experience from a single operator. Eur J Radiol 2002; 41(1): 65-69.
[20] Torres MA, Valdez-Ortiz R, Gonzalez-Parra C et al. Percutaneous renal biopsy of native kidneys: Effeciency, saftey, & risk factors associated with major complications. Arch Med Sci 2011; 7 (5): 823-831.
[21] Sugiyama H, Yokoyama H, Sato H et al. Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan. Clin Exp Nephrol 2011; 15(4): 493-503.
[22] Burstein DM, Korbet SM, Schwartz MM. The use of the automatic core biopsy system in percutaneous renal biopsies: a comparative study. Am J Kidney Dis 1993; 22(4): 545-552.
[23] Corwin HL, Schwartz MM, Lewis EJ. The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol 1988; 8(2): 85-89.
[24] Castro R, Sequeira MJ, Sameiro FM et al. Percutaneous kidney biopsy: eight years-experience. Acta Med Port 2004; 17(1): 20-26.
[25] Gonzalez-Michaca L, Chew-Wong A, Soltero L, Gamba G, Correa-Rotter R. Percutaneous kidney biopsy, analysis of 26 years: complication rate and risk factors; comment. Rev Invest Clin 2000; 52(2): 125-131.
[26] Mishra A, Tarsin R, Elhabbash B et al. Percutaneous ultrasound-guided renal biopsy. Saudi J Kidney Dis Transpl 2011; 22(4): 746-750.
[27] Whittier WL, Korbet SM. Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol 2004; 15(1): 142-147.
[28] Manno C, Strippoli GF, Arnesano L et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int 2004; 66(4): 1570-1577.
[29] Eiro M, Katoh T, Watanabe T. Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol 2005; 9(1): 40-45.
[30] Bach D, Wirth C, Schott G, Hollenbeck M, Grabensee B. Percutaneous renal biopsy: three years of experience with the biopty gun in 761 cases--a survey of results and complications. Int Urol Nephrol 1999; 31(1): 15-22.
[31] Simckes AM, Blowey DL, Gyves KM, Alon US. Success and safety of same-day kidney biopsy in children and adolescents. Pediatr Nephrol 2000; 14(10-11): 946-952.
[32] Moghazi S, Jones E, Schroepple J et al. Correlation of renal histopathology with sonographic findings. Kidney Int 2005; 67(4): 1515-1520.
[33] Rosenfield AT, Siegel NJ. Renal parenchymal disease: histopathologic-sonographic correlation. American Journal of Roentgenology 1981; 137(4): 793-798.
Cite This Article
  • APA Style

    Atef Hammad Teama, Kamal Mohamed Okasha, Sameh Ahmed Khodair, Rehab Mohamed EL-Nagar. (2015). Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases. International Journal of Medical Imaging, 3(6), 114-129. https://doi.org/10.11648/j.ijmi.20150306.13

    Copy | Download

    ACS Style

    Atef Hammad Teama; Kamal Mohamed Okasha; Sameh Ahmed Khodair; Rehab Mohamed EL-Nagar. Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases. Int. J. Med. Imaging 2015, 3(6), 114-129. doi: 10.11648/j.ijmi.20150306.13

    Copy | Download

    AMA Style

    Atef Hammad Teama, Kamal Mohamed Okasha, Sameh Ahmed Khodair, Rehab Mohamed EL-Nagar. Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases. Int J Med Imaging. 2015;3(6):114-129. doi: 10.11648/j.ijmi.20150306.13

    Copy | Download

  • @article{10.11648/j.ijmi.20150306.13,
      author = {Atef Hammad Teama and Kamal Mohamed Okasha and Sameh Ahmed Khodair and Rehab Mohamed EL-Nagar},
      title = {Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases},
      journal = {International Journal of Medical Imaging},
      volume = {3},
      number = {6},
      pages = {114-129},
      doi = {10.11648/j.ijmi.20150306.13},
      url = {https://doi.org/10.11648/j.ijmi.20150306.13},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijmi.20150306.13},
      abstract = {Objective: to evaluate the role of US &CT guided percutanous renal biopsy (PRB) in diagnosis and monitoring of renal parenchymal diseases. Patients &Methods: This study included 30 patients who were presented by and/or known cases of renal parenchymal disease referred for US and/or CT guided PRB for etiological & histopathological diagnosis. The histopathological results were correlated with clinical, US & laboratory data for each patient. Results: Out of those 30 patients; 29 patients had adequate PRB (29/30) (96.7%) for histopatholgical diagnosis. Out of those 29 patients; 23 showed increase in renal cortical echogenicity (13 with GI, 8 with GII, &2 with GIII) & 6 cases showed normal echogenicity (G0). The lupus nephritis was the most accounted diagnosis (16/29) (55.2%)(7 with GI, 5 with GII, 4 with G0 cortical echogenicity). The glomerular changes were depicted in 25 cases (13 with GI, 7 with GII, 2 with GIII, 3 with G0), tubular changes in 21 cases (10 with GI, 7 with GII, 2 with GI, 2 with G0), and interstitial changes in 24 cases (12 with GI, 8 with GII, 2 with GIII, 2 with G0). Post biopsy complications (minor) were accounted only in 2 cases (2/30) (6.7%). Conclusions: Ultrasound PRB is the standard method for most non-focal renal biopsies as it has the advantage of real-time needle placement without radiation & fundamental procedure for diagnosis, monitoring &treatment of RPD. US and CT guided PRB is generally considered safe with minimal risk.},
     year = {2015}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases
    AU  - Atef Hammad Teama
    AU  - Kamal Mohamed Okasha
    AU  - Sameh Ahmed Khodair
    AU  - Rehab Mohamed EL-Nagar
    Y1  - 2015/11/19
    PY  - 2015
    N1  - https://doi.org/10.11648/j.ijmi.20150306.13
    DO  - 10.11648/j.ijmi.20150306.13
    T2  - International Journal of Medical Imaging
    JF  - International Journal of Medical Imaging
    JO  - International Journal of Medical Imaging
    SP  - 114
    EP  - 129
    PB  - Science Publishing Group
    SN  - 2330-832X
    UR  - https://doi.org/10.11648/j.ijmi.20150306.13
    AB  - Objective: to evaluate the role of US &CT guided percutanous renal biopsy (PRB) in diagnosis and monitoring of renal parenchymal diseases. Patients &Methods: This study included 30 patients who were presented by and/or known cases of renal parenchymal disease referred for US and/or CT guided PRB for etiological & histopathological diagnosis. The histopathological results were correlated with clinical, US & laboratory data for each patient. Results: Out of those 30 patients; 29 patients had adequate PRB (29/30) (96.7%) for histopatholgical diagnosis. Out of those 29 patients; 23 showed increase in renal cortical echogenicity (13 with GI, 8 with GII, &2 with GIII) & 6 cases showed normal echogenicity (G0). The lupus nephritis was the most accounted diagnosis (16/29) (55.2%)(7 with GI, 5 with GII, 4 with G0 cortical echogenicity). The glomerular changes were depicted in 25 cases (13 with GI, 7 with GII, 2 with GIII, 3 with G0), tubular changes in 21 cases (10 with GI, 7 with GII, 2 with GI, 2 with G0), and interstitial changes in 24 cases (12 with GI, 8 with GII, 2 with GIII, 2 with G0). Post biopsy complications (minor) were accounted only in 2 cases (2/30) (6.7%). Conclusions: Ultrasound PRB is the standard method for most non-focal renal biopsies as it has the advantage of real-time needle placement without radiation & fundamental procedure for diagnosis, monitoring &treatment of RPD. US and CT guided PRB is generally considered safe with minimal risk.
    VL  - 3
    IS  - 6
    ER  - 

    Copy | Download

Author Information
  • Radiodiagnosis & Medical Imaging Department, Faculty of Medicine, Tanta University, Tanta, Egypt

  • Internal Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt

  • Radiodiagnosis & Medical Imaging Department, Faculty of Medicine, Tanta University, Tanta, Egypt

  • Radiodiagnosis & Medical Imaging Department, Faculty of Medicine, Tanta University, Tanta, Egypt

  • Sections